What is Linear Therapies?

Linear Therapies is a company focused on the research & development of antimicrobial, anti-viral, and anti-cancer agents for the treatment of life-threatening diseases. Linear Therapies is using the breakthrough solubility technology to create new intellectual properties by formulating biologically active products into novel drugs with increased bioavailability. Linear Therapies is focusing on delivering a safe and immediate anti-pathogen specifically targeted at the COVID-19 pandemic. After accomplishing this primary objective, the company will expand the practice to address international threats including current and mutant-strains of SARS, MERS, Coronavirus, Ebola and natural and man-made threatening pathogens or bio-hazards.


Linear Therapies is proud to announce that we have completed animal trials at Scripps Research Institute in La Jolla, CA related to our COVID-19 therapeutic. The successful results are forthcoming.
Linear Therapies is pleased to announce that we have been approved for products and services on the General Services Administration (GSA) contract. These products are listed under GSA contract number 47QTCA18D0089 and can be accessed and acquired via rapid acquisition using the GSA eBuy or other purchasing actions approved by the GSA.

Reach Out

Sorry but you failed our security verification. Please contact us via one of the options on the right.

Contact Info




6564 Loisdale Court, Suite 550C
Springfield, Virginia 22150